Akt Phosphorylation of p300 at Ser-1834 Is Essential for Its Histone Acetyltransferase and Transcriptional Activity

REFERENCES

• Ait-Si-Ali, S., D. Carlisi, S. Ramirez, L. C. Upegui-Gonzalez, A. Duquet, P. Robin, B. Rudkin, A. Harel-Bellan, and D. Trouche. 1999. Phosphorylation by p44 MAP kinase/ERK1 stimulates CBP histone acetyl transferase activity in vitro. Biochem. Biophys. Res. Commun. 262:157–162.
   PubMedGoogle Scholar
• Ait-Si-Ali, S., S. Ramirez, F. X. Barre, F. Dkhissi, L. Magnaghi-Jaulin, J. A. Girault, P. Robin, M. Knibiehler, L. L. Pritchard, B. Ducommun, D. Trouche, and A. Harel-Bellan. 1998. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396:184–186.
   PubMedGoogle Scholar
• Alessi, D. R., F. B. Caudwell, M. Andjelkovic, B. A. Hemmings, and P. Cohen. 1996. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399:333–338.
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641–643.
   PubMed Web of Science ®Google Scholar
• Biggs, W. H., III, J. Meisenhelder, T. Hunter, W. K. Cavenee, and K. C. Arden. 1999. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA 96:7421–7426.
   PubMed Web of Science ®Google Scholar
• Brazil, D. P., and B. A. Hemmings. 2001. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:657–664.
   PubMed Web of Science ®Google Scholar
• Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868.
   PubMed Web of Science ®Google Scholar
• Camarero, N., A. Nadal, M. J. Barrero, D. Haro, and P. F. Marrero. 2003. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. Nucleic Acids Res. 31:1693–1703.
   PubMedGoogle Scholar
• Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363–2373.
   PubMed Web of Science ®Google Scholar
• Chen, C., C. Chou, Y. Sun, and W. Huang. 2001. Tumor necrosis factor alpha-induced activation of downstream NF-κB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion. Involvement of PKCα, tyrosine kinase, and IKK2, but not MAPKs, pathway. Cell Signal 13:543–553.
   PubMed Web of Science ®Google Scholar
• Chen, J., S. S. Halappanavar, J. R. St-Germain, B. K. Tsang, and Q. Li. 2004. Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cell Mol. Life Sci. 61:1675–1683.
   PubMed Web of Science ®Google Scholar
• Deng, W. G., Y. Zhu, and K. K. Wu. 2003. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J. Biol. Chem. 278:4770–4777.
   PubMed Web of Science ®Google Scholar
• Deng, W. G., Y. Zhu, and K. K. Wu. 2004. Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators. Blood 103:2135–2142.
   PubMedGoogle Scholar
• Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553–1577.
   PubMed Web of Science ®Google Scholar
• Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595–606.
   PubMed Web of Science ®Google Scholar
• Huang, W. C., S. T. Chan, T. L. Yang, C. C. Tzeng, and C. C. Chen. 2004. Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel α-methylene-γ-butyrolactone derivatives. Carcinogenesis 25:1925–1934.
   PubMedGoogle Scholar
• Huang, W. C., J. J. Chen, and C. C. Chen. 2003. c-Src-dependent tyrosine phosphorylation of IKKβ is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J. Biol. Chem. 278:9944–9952.
   PubMedGoogle Scholar
• Impey, S., A. L. Fong, Y. Wang, J. R. Cardinaux, D. M. Fass, K. Obrietan, G. A. Wayman, D. R. Storm, T. R. Soderling, and R. H. Goodman. 2002. Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34:235–244.
   PubMed Web of Science ®Google Scholar
• Janknecht, R., and A. Nordheim. 1996. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem. Biophys. Res. Commun. 228:831–837.
   PubMed Web of Science ®Google Scholar
• Johnson, K., C. Angelin-Duclos, S. Park, and K. L. Calame. 2003. Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development. Mol. Cell. Biol. 23:2438–2450.
   PubMedGoogle Scholar
• Kawasaki, H., L. Schiltz, R. Chiu, K. Itakura, K. Taira, Y. Nakatani, and K. K. Yokoyama. 2000. ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405:195–200.
   PubMedGoogle Scholar
• Kops, G. J., N. D. de Ruiter, A. M. De Vries-Smits, D. R. Powell, J. L. Bos, and B. M. Burgering. 1999. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398:630–634.
   PubMed Web of Science ®Google Scholar
• Legube, G., and D. Trouche. 2003. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4:944–947.
   PubMed Web of Science ®Google Scholar
• Li, J., E. Gao, and C. R. Mendelson. 1998. Cyclic AMP-responsive expression of the surfactant protein-A gene is mediated by increased DNA binding and transcriptional activity of thyroid transcription factor-1. J. Biol. Chem. 273:4592–4600.
   PubMed Web of Science ®Google Scholar
• Madge, L. A., and J. S. Pober. 2000. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells. J. Biol. Chem. 275:15458–15465.
   PubMed Web of Science ®Google Scholar
• Mayo, M. W., C. E. Denlinger, R. M. Broad, F. Yeung, E. T. Reilly, Y. Shi, and D. R. Jones. 2003. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J. Biol. Chem. 278:18980–18989.
   PubMed Web of Science ®Google Scholar
• Mink, S., B. Haenig, and K. H. Klempnauer. 1997. Interaction and functional collaboration of p300 and C/EBPβ. Mol. Cell. Biol. 17:6609–6617.
   PubMed Web of Science ®Google Scholar
• Munshi, N., M. Merika, J. Yie, K. Senger, G. Chen, and D. Thanos. 1998. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 2:457–467.
   PubMed Web of Science ®Google Scholar
• Narlikar, G. J., H. Y. Fan, and R. E. Kingston. 2002. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108:475–487.
   PubMed Web of Science ®Google Scholar
• Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959.
   PubMed Web of Science ®Google Scholar
• Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82–85.
   PubMed Web of Science ®Google Scholar
• Pan, Z. K., S. C. Christiansen, A. Ptasznik, and B. L. Zuraw. 1999. Requirement of phosphatidylinositol 3-kinase activity for bradykinin stimulation of NF-κB activation in cultured human epithelial cells. J. Biol. Chem. 274:9918–9922.
   PubMedGoogle Scholar
• Radisavljevic, Z., H. Avraham, and S. Avraham. 2000. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J. Biol. Chem. 275:20770–20774.
   PubMedGoogle Scholar
• Rahman, A., A. L. True, K. N. Anwar, R. D. Ye, T. A. Voyno-Yasenetskaya, and A. B. Malik. 2002. Gαq and Gβγ regulate PAR-1 signaling of thrombin-induced NF-κB activation and ICAM-1 transcription in endothelial cells. Circ. Res. 91:398–405.
   PubMedGoogle Scholar
• Reddy, S. A., J. H. Huang, and W. S. Liao. 2000. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J. Immunol. 164:1355–1363.
   PubMedGoogle Scholar
• Schmelzle, T., and M. N. Hall. 2000. TOR, a central controller of cell growth. Cell 103:253–262.
   PubMed Web of Science ®Google Scholar
• Schwartz, C., K. Beck, S. Mink, M. Schmolke, B. Budde, D. Wenning, and K. H. Klempnauer. 2003. Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity. EMBO J. 22:882–892.
   PubMed Web of Science ®Google Scholar
• See, R. H., D. Calvo, Y. Shi, H. Kawa, M. P. Luke, Z. Yuan, and Y. Shi. 2001. Stimulation of p300-mediated transcription by the kinase MEKK1. J. Biol. Chem. 276:16310–16317.
   PubMedGoogle Scholar
• Shikama, N., J. Lyon, and N. B. La Thangue. 1997. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell. Biol. 7:230–236.
   PubMedGoogle Scholar
• Sizemore, N., S. Leung, and G. R. Stark. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol. Cell. Biol. 19:4798–4805.
   PubMed Web of Science ®Google Scholar
• Teshima, S., H. Nakanishi, M. Nishizawa, K. Kitagawa, M. Kaibori, M. Yamada, K. Habara, A. H. Kwon, Y. Kamiyama, S. Ito, and T. Okumura. 2004. Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J. Hepatol. 40:616–623.
   PubMed Web of Science ®Google Scholar
• Vermeulen, L., W. G. De, S. Notebaert, B. W. Vanden, and G. Haegeman. 2002. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem. Pharmacol. 64:963–970.
   PubMed Web of Science ®Google Scholar
• Vettese-Dadey, M., P. A. Grant, T. R. Hebbes, C. Robinson, C. D. Allis, and J. L. Workman. 1996. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15:2508–2518.
   PubMed Web of Science ®Google Scholar
• Wade, P. A., D. Pruss, and A. P. Wolffe. 1997. Histone acetylation: chromatin in action. Trends Biochem. Sci. 22:128–132.
   PubMed Web of Science ®Google Scholar
• Yang, W., Y. H. Hong, X. Q. Shen, C. Frankowski, H. S. Camp, and T. Leff. 2001. Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J. Biol. Chem. 276:38341–38344.
   PubMed Web of Science ®Google Scholar
• Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319–324.
   PubMed Web of Science ®Google Scholar
• Yao, T. P., G. Ku, N. Zhou, R. Scully, and D. M. Livingston. 1996. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93:10626–10631.
   PubMed Web of Science ®Google Scholar
• Yuan, L. W., and J. E. Gambee. 2000. Phosphorylation of p300 at serine 89 by protein kinase C. J. Biol. Chem. 275:40946–40951.
   PubMed Web of Science ®Google Scholar
• Yuan, L. W., J. W. Soh, and I. B. Weinstein. 2002. Inhibition of histone acetyltransferase function of p300 by PKCδ. Biochim. Biophys. Acta 1592:205–211.
   PubMed Web of Science ®Google Scholar
• Zhou, B. P., Y. Liao, W. Xia, Y. Zou, B. Spohn, and M. C. Hung. 2001. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3:973–982.
   PubMed Web of Science ®Google Scholar
• Zhu, K., M. A. Amin, M. J. Kim, K. J. Katschke, Jr., C. C. Park, and A. E. Koch. 2003. A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. J. Biol. Chem. 278:21869–21877.
   PubMedGoogle Scholar